Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | GAA | P10253 | 5/20 | 0.47 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.43 |
| ▸ | CASP6 | P55212 | 4/20 | 0.43 |
| ▸ | CASP3 | P42574 | 2/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HTR7 | P34969 | 5/20 | 0.40 |
| ▸ | HTR1A | P08908 | 2/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD5 | P21918 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL143970 | 0.85 | HPGD (1.00) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL31422646 | 0.85 | HPGD (1.00) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL6328308 | 0.79 | HPGD (0.74) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL27296976 | 0.79 | HPGD (0.74) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL4463146 | 0.79 | HPGD (0.74) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL16456324 | 0.79 | HPGD (0.74) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL6765903 | 0.79 | HPGD (0.74) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL6327688 | 0.79 | HPGD (0.74) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL367429 | 0.79 | HPGD (0.68) | HPGDGAATLR9PKMTNKS | |
| SCHEMBL8539515 | 0.77 | HPGD (0.83) | HPGDGAATLR9PKMTNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2467144-A1 | COMBINATION OF PROTEASOME INHIBITORS AND ANTI-HEPATITIS MEDICATION FOR TREATING HEPATITIS | ViroLogik GmbH (DE) | 2012-06-27 | — | — | EP | claimed |
| WO-2011009961-A1 | COMBINATION OF PROTEASOME INHIBITORS AND ANTI-HEPATITIS MEDICATION FOR TREATING HEPATITIS | VIROLOGIK GMBH (DE) | 2011-01-27 | — | — | WO | claimed |
| US-20110020272-A1 | COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION | SCHUBERT ULRICH | 2011-01-27 | — | — | US | claimed |
| US-20230149295-A1 | INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-05-18 | — | — | US | disclosed |
| EP-4121111-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND FIBROTIC PULMONARY DISORDERS | University of Houston System (US) | 2023-01-25 | — | — | EP | disclosed |
| EP-4117718-A1 | INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO | University of Houston System (US) | 2023-01-18 | — | — | EP | disclosed |
| US-20210401987-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND FIBROTIC PULMONARY DISORDERS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2021-12-30 | — | — | US | disclosed |
| WO-2021188849-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND FIBROTIC PULMONARY DISORDERS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2021-09-23 | — | — | WO | disclosed |
| WO-2021183474-A1 | INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO | UNIVERSITY OF HOUSTON SYSTEM (US) | 2021-09-16 | — | — | WO | disclosed |
| US-8354440-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-01-15 | — | — | US | disclosed |
| US-8268879-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-09-18 | — | — | US | disclosed |
| US-7846962-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-12-07 | — | — | US | disclosed |
| US-20100256388-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-10-07 | — | — | US | disclosed |
| US-20100249201-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-09-30 | — | — | US | disclosed |
| US-7737172-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-06-15 | — | — | US | disclosed |
| US-20090299058-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-12-03 | — | — | US | disclosed |
| CN-101001842-A | Amido compounds and their use as pharmaceuticals | INCYTE CORP (US) | 2007-07-18 | — | — | CN | disclosed |
| US-20070099976-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-05-03 | — | — | US | disclosed |
| EP-1718611-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | The President and Fellows of Harvard College (US) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005080335-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020272-A1 | COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION | HAVCR2, PSMA6, PSMB6 | HPGD 1855/4885GAA 98/4885TLR9 841/4885 |
| US-20100256388-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | EIF2AK2, EIF5B, EIF4EBP1 | HPGD 3029/4885GAA 3345/4885TLR9 3916/4885 |
| US-20210401987-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND FIBROTIC PULMONARY DISORDERS | MMP1, MMP8, CCL11 | HPGD 641/4885GAA 3641/4885TLR9 574/4885 |
| US-20090299058-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | EIF2AK2, EIF5B, EIF4EBP1 | HPGD 3029/4885GAA 3345/4885TLR9 3916/4885 |
| US-20070099976-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | EIF2AK2, EIF5B, EIF4EBP1 | HPGD 3029/4885GAA 3345/4885TLR9 3916/4885 |
| US-20230149295-A1 | INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO | EPCAM, FABP2, TPMT | HPGD 1318/4885GAA 3567/4885TLR9 449/4885 |
| US-20100249201-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | EIF2AK2, EIF5B, EIF4EBP1 | HPGD 3029/4885GAA 3345/4885TLR9 3916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.